BSE Live
Jan 27, 16:01Prev. Close
1235.15
Open Price
1250.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 27, 15:58Prev. Close
1235.60
Open Price
1251.00
Bid Price (Qty.)
1239.80 (3150)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Dr Reddys Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 84.40 | 84.20 | 84.09 | 83.96 | 38.35 | |
| Total Share Capital | 84.40 | 84.20 | 84.09 | 83.96 | 38.35 | |
| Reserves and Surplus | 3,692.40 | 3,441.90 | 4,412.80 | 3,913.30 | 2,030.53 | |
| Total Reserves and Surplus | 3,692.40 | 3,441.90 | 4,412.80 | 3,913.30 | 2,030.53 | |
| Total Shareholders Funds | 3,776.80 | 3,526.10 | 4,496.88 | 3,997.26 | 2,068.88 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 1.05 | 0.00 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 922.30 | 1,404.30 | 1,490.43 | 2,169.55 | 2,202.65 | |
| Deferred Tax Liabilities [Net] | 75.00 | 91.40 | 99.14 | 106.21 | 78.15 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 997.30 | 1,495.70 | 1,589.57 | 2,275.76 | 2,280.80 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 561.70 | 593.30 | 477.96 | 321.11 | 914.26 | |
| Trade Payables | 1,667.90 | 1,505.60 | 1,027.46 | 979.58 | 845.91 | |
| Other Current Liabilities | 6.70 | 6.20 | 5.78 | 5.77 | 6.85 | |
| Short Term Provisions | 350.20 | 199.40 | 117.54 | 137.54 | 212.99 | |
| Total Current Liabilities | 2,586.50 | 2,304.50 | 1,628.74 | 1,444.00 | 1,980.01 | |
| Total Capital And Liabilities | 7,360.60 | 7,326.30 | 7,715.20 | 7,718.07 | 6,329.69 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | -1,111.70 | -916.60 | 487.88 | 399.07 | 485.67 | |
| Intangible Assets | 3,463.90 | 3,843.60 | 3,424.65 | 3,136.35 | 2,906.04 | |
| Capital Work-In-Progress | 762.20 | 429.60 | 267.78 | 289.78 | 139.82 | |
| Fixed Assets | 3,114.40 | 3,356.60 | 4,180.32 | 3,825.20 | 3,531.54 | |
| Non-Current Investments | 358.00 | 52.30 | 482.08 | 134.12 | 133.72 | |
| Deferred Tax Assets [Net] | 68.00 | 37.60 | 18.56 | 9.51 | 2.66 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 3,540.40 | 3,446.50 | 4,680.96 | 3,968.83 | 3,667.92 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 1,339.40 | 1,325.00 | 1,101.88 | 747.15 | 666.52 | |
| Trade Receivables | 1,159.90 | 1,440.60 | 652.17 | 781.04 | 510.44 | |
| Cash And Cash Equivalents | 660.00 | 562.30 | 745.29 | 1,861.01 | 979.62 | |
| Short Term Loans And Advances | 660.90 | 551.90 | 534.90 | 360.03 | 505.19 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 3,820.20 | 3,879.80 | 3,034.24 | 3,749.23 | 2,661.77 | |
| Total Assets | 7,360.60 | 7,326.30 | 7,715.20 | 7,718.07 | 6,329.69 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 756.00 | 161.50 | 226.78 | 216.14 | 2,416.58 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 55.87 | 55.87 | 55.87 | 55.87 | 17.49 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 2.50 | 1.30 | 1.92 | 1.19 | 1.16 | |
| Non-Current Investments Unquoted Book Value | 7.10 | 7.10 | 482.86 | 0.00 | 0.00 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
22.01.2026
Dr Reddys Labs Consolidated December 2025 Net Sales at Rs 8,753.40 crore, up 4.44% Y-o-Y
22.01.2026
Dr Reddys Labs Standalone December 2025 Net Sales at Rs 4,282.70 crore, down 14.6% Y-o-Y
22.01.2026
16.01.2026
22.01.2026
Dr Reddys Labs Consolidated December 2025 Net Sales at Rs 8,753.40 crore, up 4.44% Y-o-Y
22.01.2026
Dr Reddys Labs Standalone December 2025 Net Sales at Rs 4,282.70 crore, down 14.6% Y-o-Y
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
28.10.2025
Dr Reddys Labs Consolidated September 2025 Net Sales at Rs 8,828.30 crore, up 9.83% Y-o-Y
22.01.2025
Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth
12.07.2023
Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang
24.01.2023
Dr Reddy’s Q3 Preview | Sharp drop in net profit likely on slump in US revenues
27.10.2022
Dr Reddy’s Q2 preview: Pharma major likely to report sharp drop in net profit on weak US biz